Hyperglycaemia-associated macrophage pyroptosis accelerates periodontal inflamm-ageing.
(Journal of Clinical Periodontology; doi: 10.1111/jcpe.13517)
Pengfei Zhao, Ziqi Yue, Lulingxiao Nie, Zhihao Zhao, Qian Wang, Jiao Chen, Qi Wang
Some immune cells can die in a way that releases inflammatory substances. Researchers investigated whether high blood glucose encourages this process and affects neighbouring gum cells.
Scientists studied diabetic mice and laboratory-grown cells. They measured an inflammatory cell-death pathway and exposed gum cells to substances released by affected immune cells. They also tested metformin and experimental ways of reducing parts of the pathway.
Diabetic mice had more bone loss and markers of inflammatory cell death. In cell experiments, high glucose promoted the process, and released substances caused ageing-like changes in neighbouring gum cells. Blocking part of the pathway or using metformin reduced some responses. This supports a possible mechanism, rather than demonstrating the effects of a new clinical treatment.
The findings may help explain how high glucose changes tissue responses. They do not show that the same pathway accounts for all gum disease in diabetes or that metformin should be prescribed for periodontal disease. Cell ageing markers are laboratory measurements, not a forecast of a person’s overall ageing. Further work needs to establish whether targeting this pathway improves outcomes that matter to patients, such as keeping teeth and controlling gum inflammation.
Animal and laboratory studies allow researchers to investigate processes that cannot easily be tested in people. However, experimentally induced diabetes or gum damage does not reproduce every aspect of human disease. The timing, exposure and biological responses may differ substantially. A promising effect in this setting needs further testing for both benefit and harm before it can inform patient treatment. This paper therefore helps explain a possible mechanism; it does not establish an effective human treatment or a safe dose of an experimental substance.
Read the full article Back to ResearchHosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.
Read moreDr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on…
Read moreHosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.
Read moreDr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on the relationship between diabetes and oral health.
Read morePeriodontitis is the 6th most prevalent condition globally
Periodontitis and diabetes are bidirectionally linked
Diabetic complications are increased if you have both diseases
Successful periodontal treatment can improve blood glucose control
A four-day scientific programme featuring nearly 200 sessions, encompassing prestigious orations, state-of-the-art lectures, thought-provoking debates,…
Read more